Dec 31, 2019

Zoetis Q4 2019 Earnings Report

Zoetis reported a revenue increase of 7% and net income of $384 million for Q4 2019

Key Takeaways

Zoetis reported a strong fourth quarter and full year in 2019, with revenue reaching $1.7 billion for the quarter, a 7% increase compared to the previous year. Net income for the quarter was $384 million, or $0.80 per diluted share. The company is launching Simparica® Trio in 2020 and is focused on innovation and growth areas.

Zoetis reported revenue of $1.7 billion for Q4 2019, a 7% increase year-over-year.

Net income for Q4 2019 was $384 million, or $0.80 per diluted share.

Adjusted net income for Q4 2019 was $440 million, or $0.92 per diluted share.

The company is launching Simparica® Trio in 2020 and focusing on innovation.

Total Revenue
$1.67B
Previous year: $1.56B
+7.0%
EPS
$0.92
Previous year: $0.79
+16.5%
Companion Animal Growth
18%
US Revenue Growth
6%
International Revenue Growth
9%
Gross Profit
$1.14B
Previous year: $1.02B
+12.2%
Cash and Equivalents
$1.93B
Previous year: $1.6B
+20.7%
Free Cash Flow
$416M
Previous year: $446M
-6.7%
Total Assets
$11.5B
Previous year: $10.8B
+7.1%

Zoetis

Zoetis

Zoetis Revenue by Segment

Zoetis Revenue by Geographic Location

Forward Guidance

Zoetis is providing full year 2020 guidance, which includes Revenue between $6.650 billion to $6.800 billion, Reported diluted EPS between $3.53 to $3.65 and Adjusted diluted EPS between $3.90 to $4.00.

Positive Outlook

  • Revenue between $6.650 billion to $6.800 billion
  • Operational growth 7.0% to 9.5%
  • Adjusted cost of sales as a percentage of revenue 30% to 31%
  • Adjusted SG&A expenses $1,590 to $1,640
  • Adjusted R&D expenses $455 to $475

Revenue & Expenses

Visualization of income flow from segment revenue to net income